Clin2
NCT07242222Worth exploringRecruiting

Erdosteine for non-alcoholic fatty liver disease

Fatty Liver

Part of Digestive system clinical trials.

This trial tests whether a medicine called erdosteine can help treat non-alcoholic fatty liver disease (a condition where extra fat builds up in the liver, not caused by alcohol). It is for adults who have fatty liver confirmed by ultrasound and who do not have other serious health problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
50 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have been diagnosed with fatty liver disease using an ultrasound
  • You are not pregnant or breastfeeding
  • You do not drink heavily (more than 2 drinks per day for men, 1 for women)
  • You do not have other liver diseases like hepatitis or drug-induced liver injury
  • You do not have kidney disease, parathyroid problems, or an allergy to erdosteine

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07238985Recruiting· Phase 1/Phase 2
Cilostazol for treating nonalcoholic fatty liver disease

This study tests whether a medicine called cilostazol can help treat nonalcoholic fatty liver disease. It is for adults who have fatty liver seen on an ultrasound and do not have other liver problems.

Damietta, New Damietta
NCT06863376Recruiting· Phase 2
Carbocisteine for fatty liver disease: safety and benefit study

This study tests a medicine called carbocisteine to see if it can help treat nonalcoholic fatty liver disease (NAFLD). If you have a fatty liver and no other liver or kidney conditions, this trial may explore whether this drug is safe and effective for you.

Tanta
NCT07200934Not yet recruiting
TENS and Mediterranean diet for fatty liver

This trial tests if adding TENS (a gentle electrical stimulation therapy) to a Mediterranean-style eating plan helps control appetite and improve liver health in people with non-alcoholic fatty liver disease (NAFLD).

Giza
NCT07329946Not yet recruiting
Erdosteine for COPD inflammation

This study tests whether a medicine called erdosteine can help reduce inflammation in people with stable COPD. If you are 45 or older and have had COPD for at least a year without recent flare-ups, you may be able to join.

Milan
NCT06152991Enrolling by invitation· Phase 3
Godex for fatty liver: a Phase 3 trial

This study tests an investigational supplement called Godex Carnitine Orotate Complex to see if it helps people with nonalcoholic fatty liver disease (NAFLD) lower their liver enzymes and reduce liver fat. It may be a good option if you have elevated liver enzymes and evidence of fat in your liver.

Seoul
NCT06727279Not yet recruiting
Plant protein foods for fatty liver disease

This trial tests if special foods made from plant proteins can help people with non-alcoholic fatty liver disease (NAFLD) by improving their blood fats. You'll eat these foods while researchers check how well you tolerate them and whether they help your liver.

Hear when a new Fatty Liver trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.